Featured Articles

  1. Building Uniquity Bio: Teams, Capital, And Strategy 4/30/2025

    Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.

  2. A Better Way For BD And Commercial Teams To Evaluate Strategic Assets 4/30/2025

    To unlock value and avoid costly mistakes, life sciences BD teams must work with commercial teams to help evaluate potential deals, before key assumptions are locked in, writes Ardelyx's Shetal Vyas.

  3. Adapting To Change In The Era Of Tariffs, Tax And Regulatory Changes 4/28/2025

    Life sciences companies face an impending “tax policy trifecta” including potential TCJA expiration, U.S. trade and regulatory overhaul, and implementation of the OECD’s global minimum tax regime.

  4. Why Empathy Is Your Most Powerful Leadership Tool 4/25/2025

    Leadership is about fostering the conditions for others to succeed. Empathy shapes how teams function, how trust is built, and how workplaces grow, writes Monica Singh Avram.

  5. Essential Medicines And The Need For A Robust U.S. Supply Chain 4/23/2025

    Improvements to the U.S. supply chain are needed to reduce shortages and protect American patients. Industry, academia, regulators, and politicians will need to work together, explains Dave Stowe.

  6. Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers 4/17/2025

    The U.S. tariffs on trading partners bring a whole new set of challenges, but there are tactics and strategies companies can deploy to help offset the cost and operational impacts. 

  7. Borrowed Brilliance: Is Pharma Becoming Overly Reliant On Acquisitions? 4/15/2025

    Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why outsourcing innovation can be as risky, and costly, as internal discovery.

  8. Securing Capital At The Right Moment: How Much Should Startups Ask For? 4/11/2025

    When funding is tight, life sciences startups must be even more strategic with requested amounts, timing, and funding sources, explains Michael Brooder.

  9. How HHS Budget Cuts And Vaccine Hesitancy Threaten Clinical Trial Operations — And What Leaders Can Do 4/10/2025

    Prof. Stacey B. Lee, Ph.D., examines how the recent Department of Health and Human Services (HHS) staffing cuts and vaccine hesitancy combine to make clinical research much more challenging.

  10. Understanding Re-Narcotization Is Key To Battling Opioids Like Fentanyl 4/9/2025

    Current short-acting opioid rescue agents were not designed to counteract oral fentanyl overdoses, and the mismatch can be dangerous, explains Elysium Therapeutics' Tom Jenkins, Ph.D.